Section 32 — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Formation Bio develops drugs alongside research site partners, including health systems, academic medical centers, and independent research sites, with a focus on accelerating clinical trials in dermatology, rheumatology, and cardiometabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSaaSNew York, US
Linhao Zhang(Co-Founder)Benjamine Liu(Executive Officer, Director)
BoardAlfred Lin(Director)inMichael Moritz(Director)inScott Kupor(Director)in
Co-investorsAndreessen HorowitzSam AltmanSequoia CapitalThrive CapitalMantis CapitalSpark Capital
humans& is a frontier AI lab focused on building human-centric AI systems that prioritize people and their relationships, emphasizing innovations in reinforcement learning, memory, and user understanding to create AI that strengthens organizations and communities.
AI & Machine LearningEnterprise SoftwareSaaSEl Segundo, US
Eric Zelikman(Co-founder)Noah Goodman(Founder)inAlaarif Nooruldeen(Executive Officer, Director)
BoardKristen Green(Director)Allen Mask(Director)Jonathan Ellman(Director)
Co-investorsGV (Google Ventures)S32SV AngelNVIDIAA.Capital VenturesChamaeleon+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.